Skip to main content
. 2020 Nov 16;80(4):509–517. doi: 10.1136/annrheumdis-2020-217259

Figure 3.

Figure 3

Mean change from baseline in alkaline phosphatase (U/L) (safety analysis set). IV, intravenous; Q4W, every 4 weeks; Q8W, every 8 weeks; SC, subcutaneous.